Irsko - angličtina - HPRA (Health Products Regulatory Authority)

cephalon uk limited - tiagabine - film coated tablet - 2.5 milligram

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - tiagabine hydrochloride 11,5 mg - eq. tiagabine 10 mg - film-coated tablet - 10 mg - tiagabine hydrochloride 11.5 mg - tiagabine

Spojené státy - angličtina - NLM (National Library of Medicine)

carilion materials management - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 4 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

hospira nz ltd - tiagabine hydrochloride 11.5mg - film coated tablet - 10 mg - active: tiagabine hydrochloride 11.5mg excipient: d-alpha tocoferol hypromellose lactose macrogol 6000   purified talc titanium dioxide

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - tiagabine hydrochloride monohydrate - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - tiagabine hydrochloride monohydrate - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - tiagabine hydrochloride monohydrate - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - tiagabine hydrochloride monohydrate - oral tablet - 10mg

Spojené státy - angličtina - NLM (National Library of Medicine)

cephalon, llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 2 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

hospira nz ltd - tiagabine hydrochloride 17.2mg - film coated tablet - 15 mg - active: tiagabine hydrochloride 17.2mg excipient: d-alpha tocoferol hypromellose lactose macrogol 6000   purified talc titanium dioxide